













{"id":720,"date":"2020-11-10T16:34:49","date_gmt":"2020-11-10T15:34:49","guid":{"rendered":"http:\/\/design4paper.com\/vipartners-test-live-test-live\/?p=720"},"modified":"2020-11-27T09:42:34","modified_gmt":"2020-11-27T08:42:34","slug":"genkyotex","status":"publish","type":"post","link":"https:\/\/design4paper.com\/vipartners-test-live\/genkyotex\/","title":{"rendered":"Genkyotex"},"content":{"rendered":"\n<p>Genkyotex, a pharma company based in Geneva, is the leading developer of NOX inhibitors. The Company is developing first-in-class, small molecule therapeutics that selectively inhibit NOX enzymes. Genkyotex has built a pipeline of NOX inhibitors for different diseases led by the NOX1&amp;4 inhibitor GKT137831, which is in advanced clinical development in several blockbuster indications.<\/p>\n\n\n\n<p>Genticel has acquired 100% of the shares in Genkyotex and issued new shares in consideration of the deal resulting Genkyotex\u2019s shareholders taking an 80% stake in Genticel. Total deal value EUR 150m.<\/p>\n\n\n\n<p>Learn more on <a rel=\"noreferrer noopener nofollow\" href=\"https:\/\/www.genkyotex.com\" target=\"_blank\">https:\/\/www.genkyotex.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Genkyotex, a pharma company based in Geneva, is the leading developer of NOX inhibitors. The Company is developing first-in-class, small molecule therapeutics that selectively inhibit NOX enzymes. Genkyotex has built a pipeline of NOX inhibitors for different diseases led by the NOX1&amp;4 inhibitor GKT137831, which is in advanced clinical development in several blockbuster indications. Genticel<a class=\"moretag\" href=\"https:\/\/design4paper.com\/vipartners-test-live\/genkyotex\/\"> Read the full article&#8230;<\/a><\/p>\n","protected":false},"author":3,"featured_media":335,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"aside","meta":[],"categories":[11,13,4,16],"tags":[],"_links":{"self":[{"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/posts\/720"}],"collection":[{"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/comments?post=720"}],"version-history":[{"count":3,"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/posts\/720\/revisions"}],"predecessor-version":[{"id":880,"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/posts\/720\/revisions\/880"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/media\/335"}],"wp:attachment":[{"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/media?parent=720"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/categories?post=720"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/tags?post=720"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}